Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.
The DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
Regional body fat distribution has an important influence on metabolic and cardiovascular risk factors. Increased abdominal (visceral) fat accumulation is a risk factor for coronary artery disease (CAD), dyslipidemia, hypertension, stroke, and type 2 diabetes. The recent emphasis on treatment of the dyslipidemia of the metabolic syndrome (hypertriglyceridemia, reduced high-density lipoprotein, and increased small, dense low-density lipoprotein particle number) has compelled practitioners to consider lipid-lowering therapy in a greater number of their patients, as one in two individuals over age 50 has the metabolic syndrome. Individuals with the metabolic syndrome typically have normal low-density lipoprotein cholesterol levels, and current lipid-lowering guidelines may underestimate their cardiovascular risk. Two subgroups of patients with the metabolic syndrome are at particularly high risk for premature CAD. One, individuals with type 2 diabetes, accounts for 20–30% of early cardiovascular disease. The second, familial combined hyperlipidemia, accounts for an additional 10–20% of premature CAD. Familial combined hyperlipidemia is characterized by the metabolic syndrome in addition to a disproportionate elevation of apolipoprotein B levels. The measurement of fasting glucose and apolipoprotein B, in addition to the fasting lipid profile, can help to estimate CAD risk in patients with the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In patients with the metabolic syndrome, treated type 2 diabetes mellitus, or FCHL, the number of small, dense LDL and HDL particles and the apoB levels are increased (25,26).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [26]
In the citing paper
“Type 2 diabetes mellitus, polycystic ovary syndrome, and FCHL may account for at least 40 -50% of premature coronary artery disease in some populations with metabolic syndrome, and they need to be considered in assessing the risk of CVD in patients who have the metabolic syndrome (26).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [26]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074
Larsson, B., Svärdsudd, K., Welin, L., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1984) · BMJ · doi:10.1136/bmj.288.6428.1401 · Cited by 1,934
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Cited by
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
Simental-Mendía, L. E., Rodríguez-Morán, M., & Guerrero-Romero, F. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0034 · Cited by 2,445
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Socransky, S. S., & Haffajee, A. D. (2005) · Periodontology 2000 · doi:10.1111/j.1600-0757.2005.00107.x · Cited by 1,691
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
“Type 2 diabetes mellitus, polycystic ovary syndrome, and FCHL may account for at least 40–50% of premature coronary artery disease in some populations with metabolic syndrome, and they need to be considered in assessing the risk of CVD in patients who have the metabolic syndrome (26).”
Self-citationEuropean guidelines on cardiovascular disease prevention in clinical practice: Executive summary
Graham, I. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.024 · Cited by 722
Lipoprotein Management in Patients With Cardiometabolic Risk
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Diabetes Care · doi:10.2337/dc08-9018 · Cited by 707
Self-citationFain, J. N. (2006) · Vitamins & Hormones · doi:10.1016/s0083-6729(06)74018-3 · Cited by 679
Bays, H. E., González-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W., & Henry, R. R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.343 · Cited by 530
Lipoprotein Management in Patients With Cardiometabolic Risk
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.034 · Cited by 529
Self-citationSchneider, H. J., Friedrich, N., Klotsche, J., Pieper, L., Nauck, M., John, U., Dörr, M., Felix, S., Lehnert, H., Pittrow, D., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1584 · Cited by 457
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000200416.65370.a0 · Cited by 435
Cheng, K.-H., Chu, C.-S., Lee, K.-T., Lin, T.-H., Hsieh, C.-C., Chiu, C.-C., Voon, W.-C., Sheu, S.-H., & Lai, W.-T. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803726 · Cited by 362
Accuracy of Anthropometric Indicators of Obesity to Predict Cardiovascular Risk
Schneider, H. J., Glaesmer, H., Klotsche, J., Böhler, S., Lehnert, H., Zeiher, A. M., März, W., Pittrow, D., Stalla, G. K., Wittchen, H.-U., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0254 · Cited by 299
Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., Backer, G. D., Ebrahim, S., Gjelsvik, B., et al. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000277984.31558.c4 · Cited by 281
Frank, N., Elliott, S. B., Brandt, L. E., & Keisler, D. H. (2006) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.228.9.1383 · Cited by 280
Brunzell, J. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070061 · Cited by 268
Self-citationPurnell, J. Q., Zinman, B., & Brunzell, J. D. (2013) · Circulation · doi:10.1161/circulationaha.111.077487 · Cited by 267
Self-citationThe Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors
Webb, S. J., Geoghegan, T. E., Prough, R. A., & Michael Miller, K. K. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600569877 · Cited by 237
Chung, C. P., Oeser, A., Solus, J. F., Gebretsadik, T., Shintani, A., Avalos, I., Sokka, T., Raggi, P., Pincus, T., & Stein, C. M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23600 · Cited by 230
Insulin Resistance and Type 2 Diabetes in High-Fat–Fed Mice Are Linked to High Glycotoxin Intake
Sandu, O., Song, K., Cai, W., Zheng, F., Uribarri, J., & Vlassara, H. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2314 · Cited by 213
Risk Factors for Ischaemic Stroke
Allen, C. L., & Bayraktutan, U. (2008) · International Journal of Stroke · doi:10.1111/j.1747-4949.2008.00187.x · Cited by 213
Effects of Di(2-ethylhexyl) Phthalate (DEHP) on Female Fertility and Adipogenesis in C3H/N Mice
Schmidt, J.-S., Schaedlich, K., Fiandanese, N., Pocar, P., & Fischer, B. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104016 · Cited by 211
Paniagua, J. A. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i19.483 · Cited by 197
Nordström, E. A., Rydén, M., Backlund, E. C., Dahlman, I., Kaaman, M., Blomqvist, L., Cannon, B., Nedergaard, J., & Arner, P. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1726 · Cited by 192
Obayashi, K., Saeki, K., Iwamoto, J., Okamoto, N., Tomioka, K., Nezu, S., Ikada, Y., & Kurumatani, N. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2874 · Cited by 189
Xie, L., Su, H., Sun, C., Zheng, X., & Chen, W. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.12.002 · Cited by 187
Shamai, L., Lurix, E., Shen, M., Novaro, G. M., Szomstein, S., Rosenthal, R., Hernandez, A. V., & Asher, C. R. (2011) · Obesity Surgery · doi:10.1007/s11695-010-0170-7 · Cited by 183
Dietary Magnesium and Cardiovascular Disease: A Review with Emphasis in Epidemiological Studies
Rosique-Esteban, N., Guasch-Ferré, M., Hernández-Alonso, P., & Salas-Salvadó, J. (2018) · Nutrients · doi:10.3390/nu10020168 · Cited by 177
Association of Plasma Vitamin D Levels with Adiposity in Hispanic and African Americans
Young, K. A., Engelman, C. D., Langefeld, C. D., Hairston, K. G., Haffner, S. M., Bryer-Ash, M., & Norris, J. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0079 · Cited by 167
Guo, R., Zhang, Y., Turdi, S., & Ren, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.013 · Cited by 164
Lee, S. J., Bose, S., Seo, J.-G., Chung, W.-S., Lim, C.-Y., & Kim, H. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2013.12.006 · Cited by 164
Sam, S., Haffner, S., Davidson, M. H., D'Agostino, R. B., Feinstein, S., Kondos, G., Perez, A., & Mazzone, T. (2009) · Diabetes Care · doi:10.2337/dc09-0412 · Cited by 163
Machann, J., Thamer, C., Schnödt, B., Stefan, N., Stümvoll, M., Häring, H.-U., Claussen, C. D., Schick, F., & Fritsche, A. (2005) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-005-0104-x · Cited by 167
Oral drug delivery platforms for biomedical applications
Ouyang, J., Zhang, Z., Deng, B., Liu, J., Wang, L., Liu, H., Koo, S., Chen, S., Li, Y., Yaremenko, A. V., et al. (2023) · Materials Today · doi:10.1016/j.mattod.2023.01.002 · Cited by 148
Rodriguez, A., Catalan, V., Gomez-Ambrosi, J., & Fruhbeck, G. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039599 · Cited by 133
Today's and yesterday's of pathophysiology: Biochemistry of metabolic syndrome and animal models
Aydın, S., Aksoy, A., Aydın, S., Kalaycı, M. Z., Yılmaz, M., Kuloğlu, T., Çitil, C., & Çatak, Z. (2013) · Nutrition · doi:10.1016/j.nut.2013.05.013 · Cited by 148
Oleuropein: A natural antioxidant molecule in the treatment of metabolic syndrome
Ahamad, J., Toufeeq, I., Khan, M. A., Ameen, M. S. M., Anwer, E. T., Uthirapathy, S., Mir, S. R., & Ahmad, J. (2019) · Phytotherapy Research · doi:10.1002/ptr.6511 · Cited by 153
Dudina, A., Cooney, M. T., Bacquer, D. D., Backer, G. D., Ducimetière, P., Jousilahti, P., Keil, U., Menotti, A., Njølstad, I., Oganov, R., et al. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826711412039 · Cited by 127
Deep Subcutaneous Adipose Tissue: A Distinct Abdominal Adipose Depot
Walker, G. E., Verti, B., Marzullo, P., Savia, G., Mencarelli, M., Zurleni, F., Liuzzi, A., & Di Blasio, A. M. (2007) · Obesity · doi:10.1038/oby.2007.231 · Cited by 127
Li, Q., Liu, Z., Huang, J., Luo, G., Liang, Q., Wang, D., Ye, X., Wu, C., Wang, L., & Hu, J. (2012) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.5887 · Cited by 136
Metabolic Syndrome, Obesity, and Related Risk Factors Among College Men and Women
Morrell, J. S., Lofgren, I. E., Burke, J. D., & Reilly, R. A. (2012) · Journal of American College Health · doi:10.1080/07448481.2011.582208 · Cited by 119
Cardiovascular Morbidity and Mortality of the Metabolic Syndrome
Obunai, K., Jani, S., & Dangas, G. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.003 · Cited by 134
Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status
Mesch, V., Boero, L. E., Siseles, N., Royer, M., de Prada, M. G., Sayegh, F., Schreier, L. E., Benencia, H., & Berg, G. A. (2006) · Climacteric · doi:10.1080/13697130500487331 · Cited by 119
Fenofibrate: treatment of hyperlipidemia and beyond
Rosenson, R. S. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.10.1319 · Cited by 124
Shabsigh, R., Arver, S., Channer, K. S., Eardley, I., Fabbri, A., Gooren, L., Heufelder, A., Jones, H., Meryn, S., & Zitzmann, M. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01696.x · Cited by 106
Wang, H., Kan, W., Cheng, T., Yu, S.-H., Chang, L.-H., & Chuu, J. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.04.008 · Cited by 118
Topography mapping of whole body adipose tissue using A fully automated and standardized procedure
Würslin, C., Machann, J., Rempp, H., Claussen, C., Yang, B., & Schick, F. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22036 · Cited by 103
Baek, J.-H., Kim, S.-J., Kang, H.-G., Lee, H., Kim, J., Hwang, K., Song, J., & Chun, K. (2014) · Endocrinology · doi:10.1210/en.2014-1374 · Cited by 112
The role of testosterone in the metabolic syndrome: A review
Saad, F., & Gooren, L. J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.022 · Cited by 111
The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus
Sarodnik, C., Bours, S., Schaper, N. C., van den Bergh, J. P., & van Geel, T. A. C. M. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.12.011 · Cited by 111
Banim, P. J. R., Luben, R., Bulluck, H., Sharp, S. J., Wareham, N. J., Khaw, K., & Hart, A. R. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283477cc9 · Cited by 102
Arner, P. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.012 · Cited by 100
The visfatin gene is associated with glucose and lipid metabolism in a Chinese population
Jian, W., Luo, T. ‐., Gu, Y., Zhang, H. ‐., Zheng, S., Dai, M., Han, J., Zhao, Y. Y., Li, G., & Luo, M. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01909.x · Cited by 110
Macrophage VLDLR mediates obesity-induced insulin resistance with adipose tissue inflammation
Shin, K. C., Hwang, I., Choe, S. S., Park, J., Ji, Y., Kim, J. I., Lee, G. Y., Choi, S. H., Ching, J., Kovalik, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01232-w · Cited by 107
Wang, X., Yang, Z., Xu, X., Jiang, H., Cai, C., & Yu, G. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116261 · Cited by 100
Atherogenic index of plasma is an effective index for estimating abdominal obesity
Shen, S., Lu, Y., Li, F., Yang, C., Feng, Y.-B., Li, H., Yao, W., & Shen, Z. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0656-1 · Cited by 99
The Metabolic Syndrome: A Concept Hard to Define
Aguilar-Salinas, C. A., Rojas, R., Gomez-Perez, F. J., Mehta, R., Franco, A., Oláiz, G., & Rull, J. A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.12.003 · Cited by 104
Pinchevsky, Y., Butkow, N., Raal, F. J., Chirwa, T. F., & Rothberg, A. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s226010 · Cited by 109
Guasch‐Ferré, M., Bulló, M., Martínez‐González, M. Á., Corella, D., Estruch, R., Covas, M., Arós, F., Wärnberǵ, J., Fiol, M., Lapetra, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043275 · Cited by 103
Civeira, F., Jarauta, E., Cenarro, A., García-Otín, A. L., Tejedor, D., Zambón, D., Mallen, M., Ros, E., & Pocoví, M. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.050 · Cited by 84
Ragab, S. M. M., Abd‐Elghaffar, S. K., El‐Metwally, T. H., Badr, G., Mahmoud, M. H., & Omar, H. E.-D. M. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0087-1 · Cited by 86
Saad, F., & Gooren, L. J. (2011) · Journal of Obesity · doi:10.1155/2011/471584 · Cited by 82
de Jongh, R. T., IJzerman, R. G., Serné, E. H., Voordouw, J. J., Yudkin, J. S., de Waal, H. A. D., Stehouwer, C. D. A., & van Weissenbruch, M. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1103 · Cited by 93
Prospective study of body size and risk for stroke amongst women below age 60
LU, M., YE, W., ADAMI, H. ‐., & WEIDERPASS, E. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01706.x · Cited by 79
Goldberg, R., Temprosa, M., Otvos, J., Brunzell, J., Marcovina, S., Mather, K., Arakaki, R., Watson, K., Horton, E., & Barrett-Connor, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1452 · Cited by 74
Self-citationAmelioration of diet-induced diabetes mellitus by removal of visceral fat
Pitombo, C., Araújo, E. P., De Souza, C. T., Pareja, J. C., Geloneze, B., & Velloso, L. A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.07069 · Cited by 78
Waist-to-height ratio is an effective indicator for comprehensive cardiovascular health
Shen, S., Lu, Y., Qi, H., Li, F., Shen, Z., Wu, L., Yang, C., Wang, L., Shui, K., Yao, W., et al. (2017) · Scientific Reports · doi:10.1038/srep43046 · Cited by 87
Stanstrup, J., Schou, S. S., Holmer-Jensen, J., Hermansen, K., & Dragsted, L. O. (2014) · Journal of Proteome Research · doi:10.1021/pr401214w · Cited by 76
Li, S., Guerin-Deremaux, L., Pochat, M., Wils, D., Reifer, C., & Miller, L. E. (2010) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h10-074 · Cited by 75
Adiposopathy: why do adiposity and obesity cause metabolic disease?
Bays, H., & Ballantyne, C. (2006) · Future Lipidology · doi:10.2217/17460875.1.4.389 · Cited by 74
Hypocaloric feeding of obese patients in the intensive care unit
Dickerson, R. N. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200503000-00014 · Cited by 81
Lewis, G. F., Murdoch, S. J., Uffelman, K. D., Naples, M., Szeto, L., Albers, A., Adeli, K., & Brunzell, J. D. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2893 · Cited by 77
Self-citationMelmer, A., Lamina, C., Tschoner, A., Ress, C., Kaser, S., Laimer, M. W., Sandhofer, A., Paulweber, B., & Ebenbichler, C. F. (2013) · Obesity · doi:10.1002/oby.20289 · Cited by 79
Li, L., & Wang, P. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi105 · Cited by 77
The Genetics of Obesity and the Metabolic Syndrome
Monda, K. L., North, K. E., Hunt, S. C., Rao, D. C., Province, M. A., & Kraja, A. T. (2010) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153010791213100 · Cited by 79
Fadaei, R., Moradi, N., Baratchian, M., Aghajani, H., Malek, M., Fazaeli, A., & Fallah, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168773 · Cited by 67
Holmer-Jensen, J., Mortensen, L. S., Astrup, A. V., de Vrese, M., Holst, J. J., Thomsen, C., & Hermansen, K. (2013) · Nutrition Research · doi:10.1016/j.nutres.2012.11.004 · Cited by 71
Wang, L., Xu, B., Sagada, G., Ng, W., Chen, K., Zhang, J., & Shao, Q. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520003025 · Cited by 63
Oshaghi, E. A., Goodarzi, M. T., Higgins, V., & Adeli, K. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1343274 · Cited by 68
Ashraf, A. P., Alvarez, J. A., Gower, B. A., Saenz, K. H., & McCormick, K. L. (2011) · Obesity · doi:10.1038/oby.2011.110 · Cited by 71
Anorexia Nervosa and Body Fat Distribution: A Systematic Review
Ghoch, M. E., Calugi, S., Lamburghini, S., & Grave, R. D. (2014) · Nutrients · doi:10.3390/nu6093895 · Cited by 66
Overweight and obesity: The pathogenesis of cardiometabolic risk
Bray, G. A., Clearfield, M. B., Fintel, D. J., & Nelinson, D. S. (2009) · Clinical cornerstone · doi:10.1016/s1098-3597(09)80003-3 · Cited by 75
Ghoch, M. E., Milanese, C., Calugi, S., Pellegrini, M., Battistini, N., & Grave, R. D. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.078816 · Cited by 72
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments
Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813942 · Cited by 69
Brunzell, J. D., Zambon, A., & Deeb, S. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.008 · Cited by 72
Self-citationMapping body fat distribution: A key step towards the identification of the vulnerable patient?
Arsenault, B. J., Beaumont, E. P., Després, J.-P., & Larose, E. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.605387 · Cited by 58
Metalloproteinases in metabolic syndrome
Berg, G. A., Miksztowicz, V., & Schreier, L. E. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.06.013 · Cited by 62
Dyslipidemia in midlife women: Approach and considerations during the menopausal transition
Torosyan, N., Visrodia, P., Torbati, T., Minissian, M., & SHUFELT, C. L. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.08.001 · Cited by 66
Betel nut chewing and other risk factors associated with obesity among Taiwanese male adults
Chang, W.-C., Hsiao, C.-F., Chang, H.-Y., Lan, T.-Y., Hsiung, C.-A., Shih, Y.-T., & Tai, T.-Y. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803053 · Cited by 56
Combination therapy of statins and fibrates in the management of cardiovascular risk
Fiévet, C., & Staels, B. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328332e9ef · Cited by 60
Soewondo, P., Purnamasari, D., Oemardi, M., Waspadji, S., & Soegondo, S. (2010) · PubMed · Cited by 53
Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis
Tkáč, I. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.002 · Cited by 59
Badawi, A. F., DaCosta, Arora, Garcia-Bailo, Karmali, M. A., & El‐Sohemy, A. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s35115 · Cited by 55
Barghchi, H., Dehnavi, Z., Nattagh‐Eshtivani, E., Alwaily, E. R., Almulla, A. F., Kareem, A. K., Barati, M., Ranjbar, G., Mohammadzadeh, A., Rahimi, P., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114624 · Cited by 56
Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50
Self-citationMiller, W. M., Janosz, K. E. N., Lillystone, M. A., Yanez, J., & McCullough, P. A. (2005) · Current Cardiology Reports · doi:10.1007/s11886-005-0065-8 · Cited by 61
Metadata
- Authors
- Carr, M. C., & Brunzell, J. D.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- ORCID
- Brunzell, John D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-06-01
- Volume
- 89
- Issue
- 6
- Pages
- 2601-2607
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2163802092
- Cited by
- 493
- References
- 83
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 13 · 2021: 19 · 2020: 20 · 2019: 17 · 2018: 46 · 2017: 19 · 2016: 18 · 2015: 18 · 2014: 29 · 2013: 27 · 2012: 20
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL030086, HL3-0086, HL 64322, R01HL064322)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 02456)
- National Center for Research Resources (K23RR16067, M01-RR 00037, K23RR016067, M01RR000037)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- abdominal obesity, visceral fat, metabolic syndrome, dyslipidemia, type 2 diabetes, familial combined hyperlipidemia, coronary artery disease risk, apolipoprotein B, lipid-lowering therapy, cardiovascular risk assessment, fasting blood glucose, small dense LDL, HDL cholesterol
- MeSH terms
- Abdomen, Coronary Artery Disease, Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperlipidemia, Familial Combined, Obesity, Risk Factors, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.